103 related articles for article (PubMed ID: 37650745)
1. Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR-3619-5p/MED19 axis.
Chen C; Wang N; Huang T; Cheng G; Hu Y; Wang B; Zhang Y; Wang C
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23524. PubMed ID: 37650745
[TBL] [Abstract][Full Text] [Related]
2. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
Zhang X; Gao D; Fang K; Guo Z; Li L
Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
[TBL] [Abstract][Full Text] [Related]
3. The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.
He GY; Hu JL; Zhou L; Zhu XH; Xin SN; Zhang D; Lu GF; Liao WT; Ding YQ; Liang L
Br J Cancer; 2016 Nov; 115(11):1367-1378. PubMed ID: 27811858
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
[TBL] [Abstract][Full Text] [Related]
5. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
6. Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression.
Zhang X; Fan Y; Liu B; Qi X; Guo Z; Li L
Breast Cancer; 2017 May; 24(3):433-441. PubMed ID: 27572702
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA
Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
[No Abstract] [Full Text] [Related]
8. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
Ke S; Fang M; Li R; Wang J; Lu J
Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
[TBL] [Abstract][Full Text] [Related]
9. Suppression of MED19 expression by shRNA induces inhibition of cell proliferation and tumorigenesis in human prostate cancer cells.
Cui X; Xu D; Lv C; Qu F; He J; Chen M; Liu Y; Gao Y; Che J; Yao Y; Yu H
BMB Rep; 2011 Aug; 44(8):547-52. PubMed ID: 21871180
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
Zhao W; Geng D; Li S; Chen Z; Sun M
Cancer Med; 2018 Mar; 7(3):842-855. PubMed ID: 29473328
[TBL] [Abstract][Full Text] [Related]
11. LINC02086 promotes cell viability and inhibits cell apoptosis in breast cancer by sponging miR-6757-5p and up-regulating EPHA2.
Han X; Shi F; Guo S; Li Y; Wang H; Song C; Wu S
World J Surg Oncol; 2023 Nov; 21(1):371. PubMed ID: 38008720
[TBL] [Abstract][Full Text] [Related]
12. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
15. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
[No Abstract] [Full Text] [Related]
17. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
18. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway.
Wen J; Li X; Ding Y; Zheng S; Xiao Y
Neuroreport; 2021 Jan; 32(1):52-60. PubMed ID: 33252475
[TBL] [Abstract][Full Text] [Related]
19. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis.
Zhao L; Han S; Hou J; Shi W; Zhao Y; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16341-16352. PubMed ID: 34126594
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
